Recombinant Escherichia coli pncA Protein ，His & Myc

PNCA, or pyrazinamidase/Nicatinamide adenine dinucleotide (NAD) hydrolase, is an essential enzyme in Mycobacterium tuberculosis, responsible for the activation of pyrazinamide, a crucial anti-tuberculosis drug. Understanding the functional dynamics of recombinant PNCa is vital for elucidating the mechanisms of drug resistance and the bacterium's metabolic pathways. Research into PNCa has gained momentum due to the rising incidence of multidrug-resistant tuberculosis, which poses significant challenges to global public health. Studies have shown that mutations in the pncA gene can lead to resistance against pyrazinamide, making it imperative to characterize the enzyme's structure and function. The recombinant expression of PNCa allows researchers to investigate its biochemical properties, substrate specificity, and interaction with inhibitors, ultimately aiming to identify potential therapeutic targets. Additionally, the exploration of PNCa's role in metabolism can shed light on its contribution to the survival and virulence of M. tuberculosis under varying environmental conditions. This research not only enhances our understanding of the pathogen's biology but also contributes to the development of more effective treatment strategies against tuberculosis. As such, the investigation of recombinant PNCa is a crucial step toward overcoming the challenges posed by antibiotic resistance and improving patient outcomes in tuberculosis treatment.